Advertisement

Characterization of a New Endothelin Receptor Ligand by In Vitro Assays

  • J. Ruth Wu-Wong
Protocol
  • 401 Downloads
Part of the Methods in Molecular Biology™ book series (MIMB, volume 206)

Abstract

Following the discovery of endothelin (1), functional characterization of the three endothelin (ET) isoforms (ET-1, ET-2 and ET-3) predicted that two mammalian receptor subtypes are present: the ETA receptor that is selective for ET-1, and the ETB receptor that has equal affinity for the three isoforms (2). The existence of the two distinct high-affinity ET receptor subtypes has been confirmed by cloning. Unique cDNAs that code for ETA and ETB belonging to the G-protein linked heptahelical receptor superfamily are identified in human, bovine and rat tissues (3, 4, 5, 6). While pharmacological studies suggest that there may be more ET receptor subtypes (7), no additional homologous mammalian cDNAs have been identified.

Keywords

Binding Study Test Agent Arachidonic Acid Release Receptor Binding Study Coronary Artery Smooth Muscle Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–414.PubMedCrossRefGoogle Scholar
  2. 2.
    Opgenorth T. J. (1995) Endothelin receptor antagonism. Adv. Pharmacol. 33, 1–65.PubMedCrossRefGoogle Scholar
  3. 3.
    Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. (1990) Cloning and expression of a cDNA encoding an ET receptor. Nature 348, 730–732.PubMedCrossRefGoogle Scholar
  4. 4.
    Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., and Masaki T. (1990) Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348, 732–735.PubMedCrossRefGoogle Scholar
  5. 5.
    Arai H., Nakao K., Takaya K., Hosoda K., Ogawa Y., Nakanishi S., and Imura H. (1993) The human endothelin-B receptor gene. J. Biol. Chem. 268, 3463–3470.PubMedGoogle Scholar
  6. 6.
    Elshourbagy N. A., Korman D. R., Wu H.-L., Sylvester D. R., Lee J. A., Nuthalaganti P., et al. (1993) Molecular characterization and regulation of the human endothelin receptors. J. Biol. Chem. 268, 3873–3879.PubMedGoogle Scholar
  7. 7.
    Bax W. and Saxena P. (1994) The current endothelin receptor classification: time for reconsideration? Trends Pharmacol. Sci. 15, 379–386.PubMedCrossRefGoogle Scholar
  8. 8.
    Simonson M. S. (1993) Endothelins: Multifunctional renal peptides. Physiol. Rev. 73, 375–411.PubMedGoogle Scholar
  9. 9.
    Wu-Wong J. R. and Opgenorth T. J. (2002) The roles of endothelins in proliferation, apoptosis, and angiogenesis. Handbook of Experimental Pharmacology, in press.Google Scholar
  10. 10.
    Wu-Wong J. R. and Opgenorth T. J. (1998) Endothelin and isoproterenol counter-regulate cAMP and mitogen-activated protein kinases. J. Cardiovasc. Pharmacol. 31, S185–S191.PubMedCrossRefGoogle Scholar
  11. 11.
    Wu-Wong J. R., Chiou W., Dickinson R. and Opgenorth T. J. (1997) Endothelin attenuates apoptosis in human smooth muscle cells. Biochem. J. 28, 733–737.Google Scholar
  12. 12.
    Shichiri M., Kato H., Marumo F., and Hirata Y. (1998) Endothelin-B receptormediated suppression of endothelial apoptosis. J. Cardiovasc. Pharmacol. 31, S138–S141.PubMedCrossRefGoogle Scholar
  13. 13.
    Webb D. J., Monge J. C., Rabelink T. J., and Yanagisawa M. (1998) Endothelin: new discoveries and rapid progress in the clinic. Trends Pharmacol. Sci. 19, 5–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., et al. (1991) Biological profile of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 50, 247–255.CrossRefGoogle Scholar
  15. 15.
    Sogabe K., Nirei H., Shoubo M., Nomoto A., Ao S., Notsu T., and Ono T. (1993) Pharmacological profile of FR139317, a novel, potent, endothelin ETA receptor antagonist. J. Pharmacol. Exp. Ther. 264, 1040–1046.PubMedGoogle Scholar
  16. 16.
    Opgenorth T. J., Adler A. L., Calzadilla S., Chiou W. J., Dayton B. D., Dixon D. B., et al. (1996) Pharmacological Characterization of A-127722: An orally active and highly potent ETA-selective receptor antagonist. J. Pharmacol. Exp. Ther. 276, 473–481.PubMedGoogle Scholar
  17. 17.
    Wu-Wong J. R., Dixon D. B., Chiou W. J., Dayton B. D., Novosad E. I., Adler A. L., et al. (1999) Pharmacology of A-216546: A Highly Selective Antagonist for The Type-A Endothelin Receptor. Eur. J. Pharmacol. 366, 189–201.PubMedCrossRefGoogle Scholar
  18. 18.
    Chiou W., Magnuson S. R., Dixon D. B., Sundy S., Opgenorth T. J., and Wu-Wong J. R. (1997) Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor. Endothelium: J. Endothelial Cell Res. 5, 179–189.Google Scholar
  19. 19.
    Wu-Wong J. R., Chiu W., Magnuson J. R., Bianchi B. R., and Lin C. W. (1996) Human astrocytoma U138MG cells express predominantly type-A endothelin receptors. Biochem. Biophys. Acta 1311, 155–163.PubMedCrossRefGoogle Scholar
  20. 20.
    Wu-Wong J. R., Chiou W., Magnuson S. R., and Opgenorth T. J. (1995) Endothelin Receptor in Human Astrocytoma U373MG Cells: Binding, Dissociation, Receptor Internalization. J. Pharmacol. Exp. Ther. 274, 499–507.PubMedGoogle Scholar
  21. 21.
    Wu-Wong J. R., Chiou W., Magnuson S. R., and Opgenorth T. J. (1994) Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochem. Biophys. Acta 1224, 288–294.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiou W. J., Wang J., Berg C. E., and Wu-Wong J. R. (1999) SV40 virus transformation down-regulates endothelin receptor. Biochem. Biophys. Acta 1450, 35–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Wu-Wong J. R., Berg C. E., Wang J., Chiou W. J., and Fissel B. (1999) Endothelin Stimulates Glucose Uptake and GLUT4 Translocation Via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes. J. Biol. Chem. 274, 8103–8110.PubMedCrossRefGoogle Scholar
  24. 24.
    Wu-Wong J. R., Chiou W., and Opgenorth T. J. (1993) Phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts. Mol. Pharmacol. 44, 422–429.PubMedGoogle Scholar
  25. 25.
    Wu-Wong J. R., Chiou W., Magnuson S. R., Witte D. G., and Lin C. W. (1993) Identification and characterization of type A endothelin receptor in MMQ cells. Mol. Pharmacol. 44, 285–291.PubMedGoogle Scholar
  26. 26.
    Nelson J. B., Hedican S. P., George D. J., Reddi A. H., Piantadosi S., Eisenberger M. A., and Simons J. W. (1995) Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Med. 1, 944–949.PubMedCrossRefGoogle Scholar
  27. 27.
    Tsukahara H., Ende H., Magazine H. I., Bahou W. F., and Goligorsky M. S. (1994) Molecular and functional characterization of the nonisopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J. Biol. Chem. 269, 21,778–21,785.PubMedGoogle Scholar
  28. 28.
    Morbidelli L., Orlando C., Maggi C. A., Ledda F., and Ziche M. (1995) Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am. J. Physiol. 269, H686–H695.PubMedGoogle Scholar
  29. 29.
    Lahav R., Heffner G., and Patterson P. H. (1999) An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc. Natl. Acad. Sci. 96, 11496–11500.PubMedCrossRefGoogle Scholar
  30. 30.
    Bagnato A., Tecce R., Di Castro V., and Catt K. J. (1997) Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res. 57, 1306–1311.PubMedGoogle Scholar
  31. 31.
    Wu-Wong J. R., Chiou W., Huang Z.-J., Vidal M. J., and Opgenorth T. J. (1994) Endothelin receptor in human pericardium smooth muscle cells: antagonist potency differs on agonist-evoked responses. Amer. J. Physiol. 267, C1185–C1195.PubMedGoogle Scholar
  32. 32.
    Oriji G. K. (1999) Endothelin-induced prostacyclin production in rat aortic endothelial cells is mediated by protein kinase C. Prostaglandins Leukot. Essent. Fatty Acids 60, 263–268.CrossRefGoogle Scholar
  33. 33.
    Cioffi C. L. and Garay M. (1993) Short-term regulation of endothelin receptormediated phosphoinositide hydrolysis and arachidonic acid release in A7r5 smooth-muscle cells. J. Cardiovasc. Pharmacol. 22, S168–S170.PubMedCrossRefGoogle Scholar
  34. 34.
    Vigne P. and Frelin C. (1994) Endothelins activate phospholipase A2 in brain capillary endothelial cells. Brain Res. 651, 342–344.PubMedCrossRefGoogle Scholar
  35. 35.
    Yousufzai S. Y. and Abdel-latif A. A. (1997) Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in cultured human ciliary muscle cells: activation of phospholipase A2. Exp. Eye Res. 65, 73–81.PubMedCrossRefGoogle Scholar
  36. 36.
    Abdel-Latif A. A., Husain S., and Yousufzai S. Y. (2000) Role of protein kinase C alpha and mitogen-activated protein kinases in endothelin-1-stimulation of cytosolic phospholipase A2 in iris sphincter smooth muscle. J. Cardiovasc. Pharmacol. 36, S117–S119.PubMedGoogle Scholar
  37. 37.
    Suzuki A., Shinoda J., Watanabe-Tomita Y., Ozaki N., Oiso Y., and Kozawa O. (1997) ETA receptor mediates the signaling of endothelin-1 in osteoblast-like cells. Bone 21, 143–146.PubMedCrossRefGoogle Scholar
  38. 38.
    Wu-Wong J. R., Dayton B. D., and Opgenorth T. J. (1996) Endothelin-1-evoked arachidonic acid release: a Ca(2+)-dependent pathway. Am. J. Physiol. 271, C869–C877.PubMedGoogle Scholar
  39. 39.
    Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. 91, 4892–4896.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  • J. Ruth Wu-Wong
    • 1
  1. 1.Abbott LaboratoriesSanta Clara

Personalised recommendations

Cite protocol

Buy options